Hélène Haegel

Company: Roche

Job title: Senior Principal Scientist, Immunosafety

Seminars:

HLA-Dependent Risk of T-cell Response to Micro-Dystrophin Transgene Product in Patients with DMD Harboring Mutations in Dystrophin N-terminal Region and Treated with AAV-based Gene Therapies 9:30 am

In silico and ex vivo investigations to understand the SAEs of immune-mediated myositis in DMD clinical trials Assessment of HLA-dependent immunogenicity risks Read more

day: Conference Day Two